Back

Fontan associated liver disease: how does it affect outcome?

29 August 2017 (12:07 - 12:30)
Organised by:
Congress Presentation Part of: Answers to tough questions in adult congenital heart disease Aortic valve disease ESC Premium Access ESC Congress 2017

About the speaker

Photo
Doctor Alexander Egbe

Mayo Clinic, Rochester (United States of America)

3 More presentations in this session

Presentation thumbnail
Pulmonary vasodilators in ACHD: what is the evidence?
Doctor B. Bouma (Amsterdam, NL)
Slides Video
Presentation thumbnail
Management of the failing sub-aortic right ventricle
Professor E. Oechslin (Toronto, CA)
Slides Video
Presentation thumbnail
Is there a role for CRT in ACHD?
Doctor T. Wong (London, GB)

Access the full session

Session thumbnail
Answers to tough questions in adult congenital heart disease

The Event

Event poster

ESC Congress 2017

29 August 2017 12:07 CET
You may be interested in
thumbnail
Congress Presentation
Patients with Fontan circulation beyond the fourth decade of life
31 August 2020
thumbnail
Webinar
Imaging in adult congenital heart disease: starter kit
20 May 2025
thumbnail
Congress Presentation
Role of liver disease in management and outcomes of european and asian patients with atrial fibrillation: a report from two regional prospective observational AF registries
28 August 2023
thumbnail
Congress Session
Top tips in managing heart failure in adult congenital heart disease
26 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources